A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

Summary

To evaluate the safety and efficacy of PRX-100 compared with aceclidine alone and vehicle in the treatment of early to moderate presbyopia.

Timeline

Start

2017-04-30

Primary completion

2018-05-20

Completion

2018-05-20

Outcome

Met primary endpoint

registry analysis (superiority test); Aceclidine+Tropicamide Combination vs Vehicle; p = 0.0009; Odds Ratio (OR) 38.436 NCT03201562 ↗

Drugs

Indications